Effect of Pecha Kucha-Based Education on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
The Effect of Education Provided Using the PechaKucha Method on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group.
Participants in the intervention group will receive individual education on symptom management during chemotherapy using the PechaKucha method. The education will be delivered as a video presentation consisting of 20 visual slides and lasting 6 minutes and 40 seconds. Participants in the control group will receive routine/standard patient education.
Symptom severity and quality of life will be assessed before the education and one week after the intervention using the Edmonton Symptom Assessment System (ESAS) and the EQ-5D. The study will compare changes in symptom severity and quality of life between the intervention and control groups to determine whether PechaKucha-based education is effective in supporting symptom management and quality of life among patients receiving chemotherapy.
研究概览
地位
详细说明
This randomized controlled experimental study is designed to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. The study is being conducted in the Chemotherapy Unit of Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital, with participant enrollment beginning in June 2026.
Participants will be assigned to an intervention group or a control group. Participants in the intervention group will receive individual education on "Symptom Management During Chemotherapy," delivered by the researchers using the PechaKucha method. The educational intervention will be presented as a video consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content addresses common chemotherapy-related symptoms and problems, including pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. Participants in the control group will receive routine/standard patient education.
Data will be collected through face-to-face interviews. At baseline, participants in both groups will complete the Patient Information Form, the Edmonton Symptom Assessment System (ESAS), and the EQ-5D. One week after the intervention, the ESAS and EQ-5D will be administered again to participants in both groups. The Patient Information Form, which is used to obtain demographic and clinical information, will be administered only at baseline.
Between-group comparisons will be performed using the independent-samples t-test or Mann-Whitney U test, as appropriate. Within-group pretest-posttest comparisons will be performed using the paired-samples t-test or Wilcoxon signed-rank test, as appropriate. Statistical significance will be set at p < 0.05.
Before participation, individuals will receive written and verbal information about the study, and informed consent will be obtained from all participants.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Asiye TAN, Ph D
- 电话号码:05055675275
- 邮箱:asiyetan@aydin.edu.tr
研究联系人备份
- 姓名:Dilek YILDIRIM, Ph D
- 电话号码:+905331421987
- 邮箱:dilekyildirim@aydin.edu.tr
学习地点
-
-
-
Istanbul、土耳其(türkiye)、34520
- 招聘中
- SBÜ Kanuni Sultan Süleyman E.A.H
-
接触:
- Asiye TAN, Ph D
- 电话号码:+90 05055675275
- 邮箱:asiyetan@aydin.edu.tr
-
接触:
- Dilek Yıldırım, Ph D
- 电话号码:+90 05331421987
- 邮箱:dilekyildirim@aydin.edu.tr
-
副研究员:
- Zülfiye Tosun Öztürkçi, MSc
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Willing to participate in the study.
- Currently receiving treatment in the chemotherapy unit.
- Aged 18 years or older, willing to participate, and able to communicate effectively.
Exclusion Criteria:
- Being under 18 years of age.
- Having cognitive or communication difficulties.
- Having a visual or hearing impairment.
- Being in an advanced or terminal stage of the disease.
- Having a physical or psychological condition that prevents active participation in the educational process.
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:PechaKucha-Based Education Group
Participants in this arm will receive individual education on "Symptom Management During Chemotherapy" delivered by the researchers using the PechaKucha method.
The education will be provided as a video presentation consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds.
The educational content covers pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
|
The intervention consists of individual education on symptom management during chemotherapy delivered by the researchers using the PechaKucha method.
The education is provided as a video presentation consisting of 20 visual slides, with each slide displayed for 20 seconds, for a total duration of 6 minutes and 40 seconds.
The educational content addresses pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
|
|
有源比较器:Routine/Standard Education Group
Participants in this arm will receive routine/standard patient education provided as part of usual care in the chemotherapy unit.
No PechaKucha-based education will be provided to participants in this group.
|
Participants assigned to the control group will receive routine/standard patient education provided as part of usual care in the chemotherapy unit.
This education does not include the PechaKucha-based symptom management education provided to the intervention group.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Symptom Severity Assessed by the Edmonton Symptom Assessment System (ESAS)
大体时间:Baseline (before the intervention) and one week after the intervention
|
The Edmonton Symptom Assessment System (ESAS) will be used to assess symptom severity in patients receiving chemotherapy.
Participants rate the severity of each symptom on a numerical scale, with higher scores indicating greater symptom severity.
The intervention group will receive symptom management education using the PechaKucha presentation format, whereas the control group will receive the same educational content using a conventional teaching method.
Both groups will also receive a brochure summarizing the educational content.
ESAS will be administered to both groups at baseline and one week after the intervention.
Changes in symptom severity from baseline will be compared between the groups.
|
Baseline (before the intervention) and one week after the intervention
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.